Pain Management in Sickle Cell Disease: Palliative Care Begins at Birth?

Author:

Benjamin Lennette

Abstract

Abstract People with sickle cell disease (SCD) are living longer, but their lives are impacted even more by the unpredictable intermittent or constant pain that is often poorly managed over a lifetime. To address this problem, an interdisciplinary team approach is needed that brings the medical professionals together for optimal compassionate care that is coordinated from the beginning of life and throughout the patient’s lifespan.The hematologist, whenever possible, should take the lead. Effective models that have been developed to address SCD pain, such as the Day Hospital, The Recidivism Project and various Home Care models, need to be integrated into an overarching plan on a continuum with an underpinning philosophy that will sustain such a program. While the focus of palliative care has been end of life, its philosophies fit the chronic disease model and support an integrated team approach to the SCD pain management dilemma. The patient-focused and family-oriented interventions can be modeled to fit “any place, any time,” outpatient, inpatient or the home, with homecare and other support systems. Such are the needs in SCD: appropriate, timely and compassionate care to prevent or relieve suffering and to preserve dignity, meaning, value and quality of life with improvement that is translational from birth until the end of life.

Publisher

American Society of Hematology

Subject

Hematology

Reference53 articles.

1. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007;13:534–542.

2. Benjamin LJ. The nature and management of acute painful episode in sickle cell disease. In: Forget BG, Higgs D, Nagel RL, Steinberg MH, eds. Disorders of Hemoglobin. Cambridge, UK: Cambridge University Press; 2001:671–710.

3. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev. 2005;19:99–110.

4. Bradshaw DH, Nakamura Y, Chapman CR. National Institutes of Health grant awards for pain, nausea, and dyspnea research: an assessment of funding patterns. J Pain. 2005;6:277–293.

5. Benjamin LJ, Dampier CD, Jacox AK, et al. Guideline for the Management of Acute and chronic Pain in Sickle-Cell Disease. APS Clinical Practice Guidelines Series No 1. Glenview, IL; 1999.

Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Exploring Healthcare Utilization Events towards PalliativeTherapy in Sickle Cell Anemia;International Journal of Innovative Science and Research Technology (IJISRT);2024-06-21

2. Preschool Pain Management Program for Young Children with Sickle Cell Disease: A Pre–Post Feasibility Study;Journal of Pediatric Psychology;2023-01-24

3. Serious Blood Disorders: A Focus on Sickle Cell Disease and Hemophilia;Palliative Care in Hematologic Malignancies and Serious Blood Disorders;2023

4. Palliative Care for Special Populations: Pediatrics;Palliative Care in Hematologic Malignancies and Serious Blood Disorders;2023

5. Evaluation design of the patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard (InAdvance): a randomised controlled trial;BMC Geriatrics;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3